Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough?

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Selective serotonin reuptake inhibitors (SSRIs) are first-line treatments for major depressive disorder and anxiety disorders.
• Short-term SSRI use guidelines are available, but long-term management guidance is lacking.
• SSRIs offer advantages in ease of titration, tolerability, and safety.

Purpose of the Study:

• To discuss the benefits and adverse consequences of long-term SSRI use.
• To provide clinical practice considerations for chronic SSRI prescribing.
• To highlight the need for active, periodic reassessment of long-term SSRI therapy.

Main Methods:

• Literature review and clinical practice discussion.
• Analysis of benefits, risks, and management strategies for chronic SSRI use.
• Focus on relapse prevention and adverse event monitoring.

Main Results:

• The primary benefit of long-term SSRI use is relapse prevention.
• General health risks associated with long-term SSRI use appear low.
• Long-term use may increase risks of tachyphylaxis and discontinuation syndrome.

Conclusions:

• Long-term SSRI use requires careful consideration of benefits versus risks.
• Active, shared decision-making between patient and prescriber is crucial for long-term SSRI management.
• Periodic monitoring is essential to reassess efficacy, safety, and tolerability.